Answered By: Mary Kaye Hooker
Last Updated: Oct 11, 2018     Views: 68

Take a look at these

  • CAMPHOR

McKenna, S. P., Doughty, N., Meads, D. M., Doward, L. C., & Pepke-Zaba, J. (2006). The Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR): A Measure of Health-Related Quality of Life and Quality of Life for Patients with Pulmonary Hypertension. Quality Of Life Research, 15(1), 103-115. doi:10.1007/s11136-005-3513-4           https://chamberlainuniversity.idm.oclc.org/login? url=http://search.ebscohost.com/login.aspx? direct=true&db=her&AN=19419959&site=eds-live&scope=site

  • Revised University of California San Francisco (UCSF) Symptom Management Conceptual Model

                https://nursing.ucsf.edu/research-center-symptom-management

  • Pulmonary Arterial Hypertension Symptom Scale

              https://www-sciencedirect-com.proxy.chamberlain.edu:8443/science/article/pii/S0897189714000731

  • The Hyper-PROinstrument

Zhi, L., Qiaojun, L., & Yanbo, Z. (2015). Development and validation of patient-reported outcomes scale for hypertension. International Journal For Quality In Health Care: Journal Of The International Society For Quality In Health Care / Isqua, 27(5), 369-376. doi:10.1093/intqhc/mzv060 https://chamberlainuniversity.idm.oclc.org/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=mdc&AN=26269517&site=eds-live&scope=site

  • Hill-Bone Compliance to High Blood Pressure Therapy Scale

Uchmanowicz, I., Jankowska-Polańska, B., Chudiak, A., Szymańska-Chabowska, A., & Mazur, G. (2016). Psychometric evaluation of the Polish adaptation of the Hill-Bone Compliance to High Blood Pressure Therapy Scale. BMC Cardiovascular Disorders, 161. doi:10.1186/s12872-016-0270-y https://chamberlainuniversity.idm.oclc.org/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=edb&AN=115282333&site=eds-live&scope=site

Pérez-Escamilla, B., Franco-Trigo, L., Moullin, J. C., Martínez-Martínez, F., & García-Corpas, J. P. (2015). Identification of validated questionnaires to measure adherence to pharmacological antihypertensive treatments. Patient Preference & Adherence, 9569-578. doi:10.2147/PPA.S76139 https://chamberlainuniversity.idm.oclc.org/login?url=http://search.ebscohost.com/login.aspx?direct=true&db=a9h&AN=102484581&site=eds-live&scope=site


NOTE: To get copies of some of these tools, there may be a need to write to the authors to request a full copy of the tool and permission to use.